Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A-375 | Vemurafenib | Saracatinib | 0.100 | 0.000 | uM | 72 | hr | 3 | 7818 | 140 | 0.4019 | 0.4364 | 0.0179 | 0.0207 |
A-375 | Vemurafenib | Saracatinib | 0.100 | 3.160 | uM | 72 | hr | 2 | 3199 | 50 | 0.1648 | 0.1687 | 0.0156 | 0.0176 |
A-375 | Vemurafenib | Saracatinib | 0.000 | 1.000 | uM | 72 | hr | 1 | 9957 | 502 | 0.4950 | 0.4801 | 0.0504 | 0.0412 |
A-375 | Vemurafenib | Saracatinib | 0.100 | 0.000 | uM | 72 | hr | 2 | 8079 | 212 | 0.4118 | 0.4364 | 0.0262 | 0.0207 |
A-375 | Vemurafenib | Saracatinib | 0.100 | 1.000 | uM | 72 | hr | 1 | 4016 | 78 | 0.2061 | 0.2010 | 0.0194 | 0.0218 |
A-375 | Vemurafenib | Saracatinib | 0.100 | 3.160 | uM | 72 | hr | 1 | 3954 | 69 | 0.2034 | 0.1687 | 0.0175 | 0.0176 |
A-375 | Vemurafenib | Saracatinib | 0.000 | 0.000 | uM | 72 | hr | 3 | 19884 | 1032 | 0.9869 | 1.0000 | 0.0519 | 0.0527 |
A-375 | Vemurafenib | Saracatinib | 0.000 | 0.316 | uM | 72 | hr | 3 | 14373 | 599 | 0.7211 | 0.7489 | 0.0417 | 0.0459 |
A-375 | Vemurafenib | Saracatinib | 0.000 | 3.160 | uM | 72 | hr | 1 | 9132 | 411 | 0.4565 | 0.3648 | 0.0450 | 0.0413 |
A-375 | Vemurafenib | Saracatinib | 0.100 | 0.000 | uM | 72 | hr | 1 | 9635 | 173 | 0.4953 | 0.4364 | 0.0180 | 0.0207 |
A-375 | Vemurafenib | Saracatinib | 0.100 | 0.316 | uM | 72 | hr | 2 | 6343 | 121 | 0.3257 | 0.3050 | 0.0191 | 0.0212 |
A-375 | Vemurafenib | Saracatinib | 0.100 | 0.316 | uM | 72 | hr | 3 | 5769 | 132 | 0.2951 | 0.3050 | 0.0229 | 0.0212 |
A-375 | Vemurafenib | Saracatinib | 0.100 | 1.000 | uM | 72 | hr | 2 | 4327 | 93 | 0.2216 | 0.2010 | 0.0215 | 0.0218 |
A-375 | Vemurafenib | Saracatinib | 0.100 | 1.000 | uM | 72 | hr | 3 | 3430 | 84 | 0.1752 | 0.2010 | 0.0245 | 0.0218 |
A-375 | Vemurafenib | Saracatinib | 0.000 | 0.000 | uM | 72 | hr | 1 | 20360 | 1046 | 1.0111 | 1.0000 | 0.0514 | 0.0527 |
A-375 | Vemurafenib | Saracatinib | 0.000 | 0.000 | uM | 72 | hr | 2 | 20251 | 1109 | 1.0021 | 1.0000 | 0.0548 | 0.0527 |
A-375 | Vemurafenib | Saracatinib | 0.000 | 0.316 | uM | 72 | hr | 1 | 16059 | 813 | 0.7981 | 0.7489 | 0.0506 | 0.0459 |
A-375 | Vemurafenib | Saracatinib | 0.000 | 0.316 | uM | 72 | hr | 2 | 14559 | 660 | 0.7276 | 0.7489 | 0.0453 | 0.0459 |
A-375 | Vemurafenib | Saracatinib | 0.000 | 1.000 | uM | 72 | hr | 2 | 9020 | 322 | 0.4553 | 0.4801 | 0.0357 | 0.0412 |
A-375 | Vemurafenib | Saracatinib | 0.000 | 1.000 | uM | 72 | hr | 3 | 9724 | 364 | 0.4900 | 0.4801 | 0.0374 | 0.0412 |
A-375 | Vemurafenib | Saracatinib | 0.000 | 3.160 | uM | 72 | hr | 2 | 6541 | 255 | 0.3291 | 0.3648 | 0.0390 | 0.0413 |
A-375 | Vemurafenib | Saracatinib | 0.000 | 3.160 | uM | 72 | hr | 3 | 6145 | 245 | 0.3089 | 0.3648 | 0.0399 | 0.0413 |
A-375 | Vemurafenib | Saracatinib | 0.100 | 0.316 | uM | 72 | hr | 1 | 5747 | 125 | 0.2943 | 0.3050 | 0.0218 | 0.0212 |
A-375 | Vemurafenib | Saracatinib | 0.316 | 0.000 | uM | 72 | hr | 1 | 4811 | 91 | 0.2471 | 0.2452 | 0.0189 | 0.0214 |
A-375 | Vemurafenib | Saracatinib | 0.100 | 3.160 | uM | 72 | hr | 3 | 2686 | 53 | 0.1378 | 0.1687 | 0.0197 | 0.0176 |